[Peace-study. Coronary heart disease: additive therapy with ACE-inhibitors?].
Böhm
M
M
Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes. michael.boehm@uniklinikum-saarland.de
D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage*; D001794:Blood Pressure / Q000187:drug effects; D002318:Cardiovascular Diseases / Q000401:mortality / Q000517:prevention & control; D017024:Chemotherapy, Adjuvant / Q000379:methods / Q000706:statistics & numerical data; D015897:Comorbidity; D003327:Coronary Disease / Q000188:drug therapy* / Q000401:mortality* / Q000503:physiopathology; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007211:Indoles / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000401:mortality / Q000517:prevention & control; D016032:Randomized Controlled Trials as Topic; D012084:Renin-Angiotensin System / Q000187:drug effects; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology
D000806:Angiotensin-Converting Enzyme Inhibitors; D007211:Indoles; C052035:trandolapril